CN111592509A - A method for copper-catalyzed synthesis of aryl (3-sulfonylbenzofuran-2-yl)methanone compounds - Google Patents
A method for copper-catalyzed synthesis of aryl (3-sulfonylbenzofuran-2-yl)methanone compounds Download PDFInfo
- Publication number
- CN111592509A CN111592509A CN202010512204.9A CN202010512204A CN111592509A CN 111592509 A CN111592509 A CN 111592509A CN 202010512204 A CN202010512204 A CN 202010512204A CN 111592509 A CN111592509 A CN 111592509A
- Authority
- CN
- China
- Prior art keywords
- aryl
- benzofuran
- sulfuryl
- arh
- ketone compound
- Prior art date
- Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
- Granted
Links
- -1 aryl (3-sulfonylbenzofuran-2-yl)methanone compounds Chemical class 0.000 title claims abstract description 33
- 238000000034 method Methods 0.000 title claims abstract description 23
- 238000003786 synthesis reaction Methods 0.000 title claims description 16
- 230000015572 biosynthetic process Effects 0.000 title claims description 12
- 238000006243 chemical reaction Methods 0.000 claims abstract description 28
- 239000003960 organic solvent Substances 0.000 claims abstract description 12
- 239000002994 raw material Substances 0.000 claims abstract description 7
- 230000002194 synthesizing effect Effects 0.000 claims abstract description 7
- 229910021595 Copper(I) iodide Inorganic materials 0.000 claims abstract description 6
- LSXDOTMGLUJQCM-UHFFFAOYSA-M copper(i) iodide Chemical compound I[Cu] LSXDOTMGLUJQCM-UHFFFAOYSA-M 0.000 claims abstract description 6
- 239000003054 catalyst Substances 0.000 claims abstract description 3
- 238000003756 stirring Methods 0.000 claims abstract description 3
- RYGMFSIKBFXOCR-UHFFFAOYSA-N Copper Chemical compound [Cu] RYGMFSIKBFXOCR-UHFFFAOYSA-N 0.000 claims abstract 3
- 238000006555 catalytic reaction Methods 0.000 claims abstract 3
- 229910052802 copper Inorganic materials 0.000 claims abstract 3
- 239000010949 copper Substances 0.000 claims abstract 3
- 238000010438 heat treatment Methods 0.000 claims abstract 2
- WEVYAHXRMPXWCK-UHFFFAOYSA-N Acetonitrile Chemical compound CC#N WEVYAHXRMPXWCK-UHFFFAOYSA-N 0.000 claims description 12
- 125000003118 aryl group Chemical group 0.000 claims description 11
- YMWUJEATGCHHMB-UHFFFAOYSA-N Dichloromethane Chemical compound ClCCl YMWUJEATGCHHMB-UHFFFAOYSA-N 0.000 claims description 9
- XEKOWRVHYACXOJ-UHFFFAOYSA-N Ethyl acetate Chemical compound CCOC(C)=O XEKOWRVHYACXOJ-UHFFFAOYSA-N 0.000 claims description 9
- YXFVVABEGXRONW-UHFFFAOYSA-N Toluene Chemical compound CC1=CC=CC=C1 YXFVVABEGXRONW-UHFFFAOYSA-N 0.000 claims description 9
- ISWSIDIOOBJBQZ-UHFFFAOYSA-N Phenol Chemical compound OC1=CC=CC=C1 ISWSIDIOOBJBQZ-UHFFFAOYSA-N 0.000 claims description 7
- RTZKZFJDLAIYFH-UHFFFAOYSA-N Diethyl ether Chemical compound CCOCC RTZKZFJDLAIYFH-UHFFFAOYSA-N 0.000 claims description 6
- IAZDPXIOMUYVGZ-UHFFFAOYSA-N Dimethylsulphoxide Chemical compound CS(C)=O IAZDPXIOMUYVGZ-UHFFFAOYSA-N 0.000 claims description 6
- ZMXDDKWLCZADIW-UHFFFAOYSA-N N,N-Dimethylformamide Chemical compound CN(C)C=O ZMXDDKWLCZADIW-UHFFFAOYSA-N 0.000 claims description 5
- 239000003480 eluent Substances 0.000 claims description 5
- 125000001997 phenyl group Chemical group [H]C1=C([H])C([H])=C(*)C([H])=C1[H] 0.000 claims description 5
- 238000010898 silica gel chromatography Methods 0.000 claims description 5
- FAPWRFPIFSIZLT-UHFFFAOYSA-M Sodium chloride Chemical class [Na+].[Cl-] FAPWRFPIFSIZLT-UHFFFAOYSA-M 0.000 claims description 4
- 239000012074 organic phase Substances 0.000 claims description 4
- WSLDOOZREJYCGB-UHFFFAOYSA-N 1,2-Dichloroethane Chemical compound ClCCCl WSLDOOZREJYCGB-UHFFFAOYSA-N 0.000 claims description 3
- RYHBNJHYFVUHQT-UHFFFAOYSA-N 1,4-Dioxane Chemical compound C1COCCO1 RYHBNJHYFVUHQT-UHFFFAOYSA-N 0.000 claims description 3
- UXVMQQNJUSDDNG-UHFFFAOYSA-L Calcium chloride Chemical compound [Cl-].[Cl-].[Ca+2] UXVMQQNJUSDDNG-UHFFFAOYSA-L 0.000 claims description 3
- ZAMOUSCENKQFHK-UHFFFAOYSA-N Chlorine atom Chemical compound [Cl] ZAMOUSCENKQFHK-UHFFFAOYSA-N 0.000 claims description 3
- 239000000460 chlorine Substances 0.000 claims description 3
- 229910052801 chlorine Inorganic materials 0.000 claims description 3
- 239000003208 petroleum Substances 0.000 claims description 3
- 125000001424 substituent group Chemical group 0.000 claims description 3
- PXGOKWXKJXAPGV-UHFFFAOYSA-N Fluorine Chemical compound FF PXGOKWXKJXAPGV-UHFFFAOYSA-N 0.000 claims description 2
- 125000001495 ethyl group Chemical group [H]C([H])([H])C([H])([H])* 0.000 claims description 2
- 229910052731 fluorine Inorganic materials 0.000 claims description 2
- 239000011737 fluorine Substances 0.000 claims description 2
- 125000001072 heteroaryl group Chemical group 0.000 claims description 2
- 229910052739 hydrogen Inorganic materials 0.000 claims description 2
- 239000001257 hydrogen Substances 0.000 claims description 2
- 125000004435 hydrogen atom Chemical class [H]* 0.000 claims description 2
- 125000002496 methyl group Chemical group [H]C([H])([H])* 0.000 claims description 2
- 239000000126 substance Substances 0.000 claims description 2
- 239000012295 chemical reaction liquid Substances 0.000 claims 3
- 238000001035 drying Methods 0.000 claims 2
- 238000011001 backwashing Methods 0.000 claims 1
- 125000001309 chloro group Chemical group Cl* 0.000 claims 1
- 238000001514 detection method Methods 0.000 claims 1
- 238000001914 filtration Methods 0.000 claims 1
- 125000001153 fluoro group Chemical group F* 0.000 claims 1
- IANQTJSKSUMEQM-UHFFFAOYSA-N 1-benzofuran Chemical compound C1=CC=C2OC=CC2=C1 IANQTJSKSUMEQM-UHFFFAOYSA-N 0.000 abstract description 11
- 238000009776 industrial production Methods 0.000 abstract description 3
- 238000000926 separation method Methods 0.000 abstract description 3
- 238000000746 purification Methods 0.000 abstract description 2
- 238000001308 synthesis method Methods 0.000 abstract 1
- 238000005481 NMR spectroscopy Methods 0.000 description 23
- 239000007787 solid Substances 0.000 description 17
- 238000004458 analytical method Methods 0.000 description 14
- 238000000655 nuclear magnetic resonance spectrum Methods 0.000 description 10
- 238000001644 13C nuclear magnetic resonance spectroscopy Methods 0.000 description 7
- 238000005160 1H NMR spectroscopy Methods 0.000 description 7
- 238000011160 research Methods 0.000 description 5
- 239000000243 solution Substances 0.000 description 5
- 125000000472 sulfonyl group Chemical group *S(*)(=O)=O 0.000 description 5
- 229940079593 drug Drugs 0.000 description 4
- 239000003814 drug Substances 0.000 description 4
- 230000004071 biological effect Effects 0.000 description 3
- 150000001907 coumarones Chemical class 0.000 description 3
- 230000007613 environmental effect Effects 0.000 description 3
- CFOAUYCPAUGDFF-UHFFFAOYSA-N tosmic Chemical compound CC1=CC=C(S(=O)(=O)C[N+]#[C-])C=C1 CFOAUYCPAUGDFF-UHFFFAOYSA-N 0.000 description 3
- 229910020366 ClO 4 Inorganic materials 0.000 description 2
- 150000001345 alkine derivatives Chemical class 0.000 description 2
- 230000000259 anti-tumor effect Effects 0.000 description 2
- 150000001875 compounds Chemical class 0.000 description 2
- 238000005859 coupling reaction Methods 0.000 description 2
- 238000011161 development Methods 0.000 description 2
- 238000004821 distillation Methods 0.000 description 2
- 230000000694 effects Effects 0.000 description 2
- VNWKTOKETHGBQD-UHFFFAOYSA-N methane Chemical compound C VNWKTOKETHGBQD-UHFFFAOYSA-N 0.000 description 2
- 229930014626 natural product Natural products 0.000 description 2
- 230000008569 process Effects 0.000 description 2
- HPALAKNZSZLMCH-UHFFFAOYSA-M sodium;chloride;hydrate Chemical class O.[Na+].[Cl-] HPALAKNZSZLMCH-UHFFFAOYSA-M 0.000 description 2
- 239000000758 substrate Substances 0.000 description 2
- 150000003457 sulfones Chemical class 0.000 description 2
- 125000002941 2-furyl group Chemical group O1C([*])=C([H])C([H])=C1[H] 0.000 description 1
- OJWYYSVOSNWCCE-UHFFFAOYSA-N 2-methoxyethyl hypofluorite Chemical compound COCCOF OJWYYSVOSNWCCE-UHFFFAOYSA-N 0.000 description 1
- PKURHFYJMWBEEX-OWOJBTEDSA-N 5-[4-hydroxy-2-(4-hydroxyphenyl)-6-[(e)-2-(4-hydroxyphenyl)ethenyl]-1-benzofuran-3-yl]benzene-1,3-diol Chemical compound C1=CC(O)=CC=C1\C=C\C1=CC(O)=C(C(=C(O2)C=3C=CC(O)=CC=3)C=3C=C(O)C=C(O)C=3)C2=C1 PKURHFYJMWBEEX-OWOJBTEDSA-N 0.000 description 1
- XFXPMWWXUTWYJX-UHFFFAOYSA-N Cyanide Chemical compound N#[C-] XFXPMWWXUTWYJX-UHFFFAOYSA-N 0.000 description 1
- 101100391174 Dictyostelium discoideum forC gene Proteins 0.000 description 1
- 241000282414 Homo sapiens Species 0.000 description 1
- 206010020772 Hypertension Diseases 0.000 description 1
- DUEWVPTZCSAMNB-UHFFFAOYSA-N Saprisartan Chemical compound NC(=O)C=1N(CC=2C=C3C(Br)=C(OC3=CC=2)C=2C(=CC=CC=2)NS(=O)(=O)C(F)(F)F)C(CC)=NC=1C1CC1 DUEWVPTZCSAMNB-UHFFFAOYSA-N 0.000 description 1
- 239000005478 Saprisartan Substances 0.000 description 1
- LEHOTFFKMJEONL-UHFFFAOYSA-N Uric Acid Chemical compound N1C(=O)NC(=O)C2=C1NC(=O)N2 LEHOTFFKMJEONL-UHFFFAOYSA-N 0.000 description 1
- TVWHNULVHGKJHS-UHFFFAOYSA-N Uric acid Natural products N1C(=O)NC(=O)C2NC(=O)NC21 TVWHNULVHGKJHS-UHFFFAOYSA-N 0.000 description 1
- 230000004913 activation Effects 0.000 description 1
- IYIKLHRQXLHMJQ-UHFFFAOYSA-N amiodarone Chemical compound CCCCC=1OC2=CC=CC=C2C=1C(=O)C1=CC(I)=C(OCCN(CC)CC)C(I)=C1 IYIKLHRQXLHMJQ-UHFFFAOYSA-N 0.000 description 1
- 229960005260 amiodarone Drugs 0.000 description 1
- PKURHFYJMWBEEX-UHFFFAOYSA-N anigopreissin A Natural products C1=CC(O)=CC=C1C=CC1=CC(O)=C(C(=C(O2)C=3C=CC(O)=CC=3)C=3C=C(O)C=C(O)C=3)C2=C1 PKURHFYJMWBEEX-UHFFFAOYSA-N 0.000 description 1
- 230000003288 anthiarrhythmic effect Effects 0.000 description 1
- 230000000843 anti-fungal effect Effects 0.000 description 1
- 230000000947 anti-immunosuppressive effect Effects 0.000 description 1
- 230000000845 anti-microbial effect Effects 0.000 description 1
- 230000002365 anti-tubercular Effects 0.000 description 1
- 230000000840 anti-viral effect Effects 0.000 description 1
- 239000003416 antiarrhythmic agent Substances 0.000 description 1
- 239000003963 antioxidant agent Substances 0.000 description 1
- 230000003078 antioxidant effect Effects 0.000 description 1
- WHQCHUCQKNIQEC-UHFFFAOYSA-N benzbromarone Chemical compound CCC=1OC2=CC=CC=C2C=1C(=O)C1=CC(Br)=C(O)C(Br)=C1 WHQCHUCQKNIQEC-UHFFFAOYSA-N 0.000 description 1
- 229960002529 benzbromarone Drugs 0.000 description 1
- CREMABGTGYGIQB-UHFFFAOYSA-N carbon carbon Chemical compound C.C CREMABGTGYGIQB-UHFFFAOYSA-N 0.000 description 1
- 239000011203 carbon fibre reinforced carbon Substances 0.000 description 1
- 230000003197 catalytic effect Effects 0.000 description 1
- 239000003153 chemical reaction reagent Substances 0.000 description 1
- 239000004020 conductor Substances 0.000 description 1
- 230000006866 deterioration Effects 0.000 description 1
- 230000008034 disappearance Effects 0.000 description 1
- 230000029142 excretion Effects 0.000 description 1
- 238000000605 extraction Methods 0.000 description 1
- 239000012634 fragment Substances 0.000 description 1
- 238000013537 high throughput screening Methods 0.000 description 1
- 150000002611 lead compounds Chemical class 0.000 description 1
- 239000003446 ligand Substances 0.000 description 1
- 238000003760 magnetic stirring Methods 0.000 description 1
- 230000001404 mediated effect Effects 0.000 description 1
- 238000006452 multicomponent reaction Methods 0.000 description 1
- 230000000269 nucleophilic effect Effects 0.000 description 1
- GXDWYPLNTDWCCT-UHFFFAOYSA-N obovaten Natural products COc1cc(cc(O)c1O)c2oc3c(OC)cc(C=CC)cc3c2C GXDWYPLNTDWCCT-UHFFFAOYSA-N 0.000 description 1
- 239000007800 oxidant agent Substances 0.000 description 1
- UCNXHCORVWTXNA-UHFFFAOYSA-N phenyl-(3-sulfonyl-1-benzofuran-2-yl)methanone Chemical class C1=CC=C(C=C1)C(=O)C2C(=S(=O)=O)C3=CC=CC=C3O2 UCNXHCORVWTXNA-UHFFFAOYSA-N 0.000 description 1
- 230000001766 physiological effect Effects 0.000 description 1
- 238000012805 post-processing Methods 0.000 description 1
- 238000002360 preparation method Methods 0.000 description 1
- 238000007363 ring formation reaction Methods 0.000 description 1
- 229950006241 saprisartan Drugs 0.000 description 1
- 229920006395 saturated elastomer Polymers 0.000 description 1
- 239000011780 sodium chloride Substances 0.000 description 1
- 238000005556 structure-activity relationship Methods 0.000 description 1
- 238000000967 suction filtration Methods 0.000 description 1
- 238000010189 synthetic method Methods 0.000 description 1
- 230000007704 transition Effects 0.000 description 1
- 229940116269 uric acid Drugs 0.000 description 1
- XLYOFNOQVPJJNP-UHFFFAOYSA-N water Substances O XLYOFNOQVPJJNP-UHFFFAOYSA-N 0.000 description 1
Images
Classifications
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07D—HETEROCYCLIC COMPOUNDS
- C07D307/00—Heterocyclic compounds containing five-membered rings having one oxygen atom as the only ring hetero atom
- C07D307/77—Heterocyclic compounds containing five-membered rings having one oxygen atom as the only ring hetero atom ortho- or peri-condensed with carbocyclic rings or ring systems
- C07D307/78—Benzo [b] furans; Hydrogenated benzo [b] furans
- C07D307/82—Benzo [b] furans; Hydrogenated benzo [b] furans with hetero atoms or with carbon atoms having three bonds to hetero atoms with at the most one bond to halogen, e.g. ester or nitrile radicals, directly attached to carbon atoms of the hetero ring
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07D—HETEROCYCLIC COMPOUNDS
- C07D307/00—Heterocyclic compounds containing five-membered rings having one oxygen atom as the only ring hetero atom
- C07D307/77—Heterocyclic compounds containing five-membered rings having one oxygen atom as the only ring hetero atom ortho- or peri-condensed with carbocyclic rings or ring systems
- C07D307/78—Benzo [b] furans; Hydrogenated benzo [b] furans
- C07D307/86—Benzo [b] furans; Hydrogenated benzo [b] furans with an oxygen atom directly attached in position 7
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07D—HETEROCYCLIC COMPOUNDS
- C07D409/00—Heterocyclic compounds containing two or more hetero rings, at least one ring having sulfur atoms as the only ring hetero atoms
- C07D409/02—Heterocyclic compounds containing two or more hetero rings, at least one ring having sulfur atoms as the only ring hetero atoms containing two hetero rings
- C07D409/06—Heterocyclic compounds containing two or more hetero rings, at least one ring having sulfur atoms as the only ring hetero atoms containing two hetero rings linked by a carbon chain containing only aliphatic carbon atoms
-
- Y—GENERAL TAGGING OF NEW TECHNOLOGICAL DEVELOPMENTS; GENERAL TAGGING OF CROSS-SECTIONAL TECHNOLOGIES SPANNING OVER SEVERAL SECTIONS OF THE IPC; TECHNICAL SUBJECTS COVERED BY FORMER USPC CROSS-REFERENCE ART COLLECTIONS [XRACs] AND DIGESTS
- Y02—TECHNOLOGIES OR APPLICATIONS FOR MITIGATION OR ADAPTATION AGAINST CLIMATE CHANGE
- Y02P—CLIMATE CHANGE MITIGATION TECHNOLOGIES IN THE PRODUCTION OR PROCESSING OF GOODS
- Y02P20/00—Technologies relating to chemical industry
- Y02P20/50—Improvements relating to the production of bulk chemicals
- Y02P20/584—Recycling of catalysts
Landscapes
- Chemical & Material Sciences (AREA)
- Organic Chemistry (AREA)
- Low-Molecular Organic Synthesis Reactions Using Catalysts (AREA)
Abstract
Description
技术领域technical field
本发明属于有机合成领域,涉及一种铜催化合成反应,具体涉及一种铜催化合成芳基(3-砜基苯并呋喃-2-基)甲酮化合物的方法。The invention belongs to the field of organic synthesis, and relates to a copper-catalyzed synthesis reaction, in particular to a method for copper-catalyzed synthesis of an aryl (3-sulfonylbenzofuran-2-yl)methanone compound.
背景技术Background technique
苯并呋喃是一类重要的有机小分子骨架,不仅是许多生物活性天然产物、药物以及有机导电材料等的关键结构单元,而且还是多用途的有机合成子,所以发展苯并呋喃的合成方法一直是有机合成化学的重要研究课题之一。在各种天然和合成苯并呋喃衍生物中,它们表现出了良好的抗肿瘤、抗病毒、抗真菌、抗氧化、抗结核、免疫抑制剂等生理活性,例如:Benzbromarone(尿酸排泄药),Amiodarone(抗心律失常药),Obovaten(抗肿瘤活性),Saprisartan(治疗高血压)和Anigopreissin A(抗微生物药)等活性。近年来,一些有效构建苯并呋喃类化合物的策略得到了充分发展(Nat.Chem.2019,11,797;Org.Lett.2019,21,955;Org.Lett.2019,21,8008;Adv.Synth.Catal.2016,358,2984;Angew.Chem.Int.Ed.2013,52,4607;J.Am.Chem.Soc.2009,131,17387etc.)。然而,这些方法大部分是对已发展策略的拓展,并不能从根本上解决苯并呋喃合成上存在的局限,缺乏实用价值。截止目前为止一种最常见合成苯并呋喃的方法是利用碱介导的亲核偶联物,随后由过渡金属催化活化炔烃与2-卤代酚Heck型环化生成目标化合物。这一公开的催化策略还存在着一些缺陷例如:区域选择性差,需要使用强氧化剂和昂贵的配体,以及各种取代基的限制,反应条件苛刻,产物产率低等。因此,这样迫切的要求科学工作者们开发新的简便、高效的方法制备苯并呋喃。Benzofuran is a kind of important organic small molecular framework, not only the key structural unit of many biologically active natural products, drugs and organic conductive materials, but also a multi-purpose organic synthon, so the development of synthetic methods of benzofuran has been It is one of the important research topics in organic synthetic chemistry. Among various natural and synthetic benzofuran derivatives, they have shown good anti-tumor, anti-viral, anti-fungal, antioxidant, anti-tuberculosis, immunosuppressive and other physiological activities, such as: Benzbromarone (uric acid excretion drug), Activities such as Amiodarone (antiarrhythmic), Obovaten (antitumor activity), Saprisartan (treatment of hypertension) and Anigopreissin A (antimicrobial). In recent years, some strategies to efficiently construct benzofurans have been fully developed (Nat.Chem.2019,11,797; Org.Lett.2019,21,955; Org.Lett.2019,21,8008; Adv.Synth.Catal. 2016, 358, 2984; Angew. Chem. Int. Ed. 2013, 52, 4607; J. Am. Chem. Soc. 2009, 131, 17387 etc.). However, most of these methods are extensions of the developed strategies, which cannot fundamentally solve the limitations of benzofuran synthesis and lack practical value. To date, one of the most common methods for synthesizing benzofurans utilizes base-mediated nucleophilic conjugates, followed by transition metal-catalyzed activation of alkynes with 2-halophenols Heck-type cyclization to the target compounds. This disclosed catalytic strategy also suffers from some drawbacks such as poor regioselectivity, the need to use strong oxidants and expensive ligands, and limitations of various substituents, harsh reaction conditions, and low product yields. Therefore, there is an urgent need for scientists to develop new simple and efficient methods to prepare benzofuran.
磺酰(砜)类是另一类普遍的片段,广泛存在于许多具有高生物活性的天然产物以及药物分子当中,在有机合成以及药物化学中极为有用。由于磺酰类化合物在药物化学中的重要地位,研究开发温和条件下基于磺酰类化合物的合成具有重要的意义,能够为含磺酰基团药物及其衍生物的合成打开一个新的通道,为有机合成提供新的手段。同时,利用发展的方法学得到的结构类似的磺酰类化合物可以直接用于一些特定生物靶体的高通量筛选中。这样的小分子化合物库一旦经过有价值的生物模型的筛选,其结果不仅可以为得到活性高,选择性好的先导化合物提供可能性,而且在此过程中得到的构效关系将会为更加准确地揭示生命过程建立更为坚实可靠的数据库。因此,将砜基官能团引入到同时具有特殊生物活性的苯并呋喃骨架中,进而广泛地培养其生物学特性具有重要的意义。然而,经过大量的文献调研发现仅有少量的例子关于它们的合成,且现有的方法普遍存在着预设计的底物分子,收率低,反应条件苛刻,反应步骤繁琐,环境不友好等缺点。近年来,铜催化的有机化学反应成为了当前有机化学研究的热点方向之一,多种铜催化的化学反应已经被报道,比如碳-碳偶联反应、碳-杂原子偶联反应、分子内反应、多组分反应等。随着全球生态环境的急剧恶化,如何实现可持续发展已成为人类面临的重大问题,以从源头上消除污染、节省资源为核心的绿色化学研究已经成为解决日益严峻的生态环境问题的强有力手段。异氰与炔的反应具有环境友好、价格低廉等优点,这些优点使其特别适合作为化学工业生产。Sulfonyl (sulfone)s are another common class of fragments that are widely found in many natural products and drug molecules with high biological activity, and are extremely useful in organic synthesis and medicinal chemistry. Due to the important position of sulfonyl compounds in medicinal chemistry, it is of great significance to research and develop the synthesis of sulfonyl compounds under mild conditions, which can open a new channel for the synthesis of sulfonyl group-containing drugs and their derivatives. Organic synthesis provides new means. At the same time, the structurally similar sulfonyl compounds obtained by the developed methodology can be directly used in the high-throughput screening of some specific biological targets. Once such a small molecule compound library has been screened by valuable biological models, the results will not only provide the possibility to obtain lead compounds with high activity and good selectivity, but also the structure-activity relationship obtained in this process will be more accurate. To reveal the life process to establish a more solid and reliable database. Therefore, it is of great significance to introduce the sulfone functional group into the benzofuran skeleton with special biological activity, and then extensively cultivate its biological properties. However, after a lot of literature research, it is found that there are only a few examples about their synthesis, and the existing methods generally have the disadvantages of pre-designed substrate molecules, low yields, harsh reaction conditions, cumbersome reaction steps, and unfriendly environment. . In recent years, copper-catalyzed organic chemical reactions have become one of the hotspots in current organic chemistry research. A variety of copper-catalyzed chemical reactions have been reported, such as carbon-carbon coupling reactions, carbon-heteroatom coupling reactions, intramolecular reactions, multicomponent reactions, etc. With the rapid deterioration of the global ecological environment, how to achieve sustainable development has become a major problem faced by human beings. Green chemistry research centered on eliminating pollution at the source and saving resources has become a powerful means to solve increasingly serious ecological and environmental problems. . The reaction of isocyanide with alkyne has the advantages of environmental friendliness and low price, and these advantages make it particularly suitable for chemical industrial production.
发明内容SUMMARY OF THE INVENTION
本发明的目的是提供一种铜催化合成芳基(3-砜基苯并呋喃-2-基)甲酮化合物的方法,原料廉价易得,环境友好。The purpose of the present invention is to provide a copper-catalyzed method for synthesizing aryl(3-sulfonylbenzofuran-2-yl)methanone compounds, the raw materials are cheap and easy to obtain, and the environment is friendly.
为实现上述目的,本发明采用的技术方案如下:一种铜催化合成芳基(3-砜基苯并呋喃-2-基)甲酮化合物的方法,在有机溶剂体系中,以式(1)所示的2-(1-羟基-3-芳基丙-2-炔-1-基)苯酚和式(2)所示的对甲苯磺酰基甲基异氰为原料,以碘化亚铜为催化剂,加热搅拌反应,通过TLC跟踪检测至反应完全,反应液后处理后得到式(3)所示的芳基(3-砜基苯并呋喃-2-基)甲酮化合物;其中,2-(1-羟基-3-芳基丙-2-炔-1-基)苯酚、对甲苯磺酰基甲基异氰的投料摩尔比为1.5:1;In order to achieve the above object, the technical scheme adopted in the present invention is as follows: a method for copper-catalyzed synthesis of aryl (3-sulfonylbenzofuran-2-yl)methanone compound, in an organic solvent system, with formula (1) The 2-(1-hydroxy-3-arylprop-2-yn-1-yl) phenol shown and the p-toluenesulfonyl methyl isocyanide shown in formula (2) are used as raw materials, and cuprous iodide is used as the raw material. The catalyst is heated and stirred for reaction, and is detected by TLC tracking until the reaction is complete, and the aryl (3-sulfonylbenzofuran-2-yl)methanone compound shown in formula (3) is obtained after the post-treatment of the reaction solution; wherein, 2- The molar ratio of (1-hydroxy-3-arylprop-2-yn-1-yl)phenol to p-toluenesulfonyl methyl isocyanide is 1.5:1;
式中,R1为氢、甲氧基、甲基、氟、氯,Ar为苯基、取代苯基、杂芳基、稠芳基,其中取代基为甲基、乙基、甲氧基、乙氧基、氟或氯。In the formula, R 1 is hydrogen, methoxy, methyl, fluorine, chlorine, Ar is phenyl, substituted phenyl, heteroaryl, condensed aryl, wherein the substituents are methyl, ethyl, methoxy, Ethoxy, fluorine or chlorine.
优选的,所述有机溶剂选自乙腈、1,2-二氯乙烷、1,4-二氧六环、N-二甲基甲酰胺、二甲基亚砜、甲苯中的一种。Preferably, the organic solvent is selected from one of acetonitrile, 1,2-dichloroethane, 1,4-dioxane, N-dimethylformamide, dimethylsulfoxide, and toluene.
更优选的,所述有机溶剂选自乙腈。More preferably, the organic solvent is selected from acetonitrile.
优选的,所述碘化亚铜的用量为式(1)所示的2-(1-羟基-3-芳基丙-2-炔-1-基)苯酚的物质的量的10mol%。Preferably, the amount of cuprous iodide used is 10 mol% of the amount of 2-(1-hydroxy-3-arylprop-2-yn-1-yl)phenol represented by formula (1).
优选的,所述反应温度为60-100℃。Preferably, the reaction temperature is 60-100°C.
优选的,所述反应液后处理的方法为:反应结束后,将反应液倾入饱和食盐水中,用二氯甲烷萃取,然后用饱和食盐水反洗有机相,经无水氯化钙干燥、抽滤、减压蒸馏后再经硅胶柱层析分离,所得洗脱液减压蒸馏,干燥,制得式(3)所示的芳基(3-砜基苯并呋喃-2-基)甲酮化合物。Preferably, the post-processing method of the reaction solution is as follows: after the reaction is completed, the reaction solution is poured into saturated brine, extracted with dichloromethane, and then the organic phase is backwashed with saturated brine, dried over anhydrous calcium chloride, Suction filtration, distillation under reduced pressure and then separation by silica gel column chromatography, the obtained eluent is distilled under reduced pressure and dried to obtain aryl(3-sulfonylbenzofuran-2-yl)methane represented by formula (3). ketone compounds.
优选的,所述硅胶柱层析的洗脱液为石油醚:乙酸乙酯=4:1,V/V。Preferably, the eluent of the silica gel column chromatography is petroleum ether:ethyl acetate=4:1, V/V.
与现有技术相比,本发明具有操作简单,原料和试剂易得,条件温和,反应体系绿色环保,产物易分离纯化,适用于合成各种高度官能化的芳基(3-砜基苯并呋喃-2-基)甲酮类化合物,特别适用于大规模的工业生产,可以高效、高收率(75%以上)地制得高纯度的芳基(3-砜基苯并呋喃-2-基)甲酮类化合物。Compared with the prior art, the present invention has the advantages of simple operation, easy availability of raw materials and reagents, mild conditions, green and environmental protection reaction system, easy separation and purification of products, and is suitable for synthesizing various highly functionalized aryl (3-sulfonyl benzoyl) compounds. Furan-2-yl)methanone compounds, especially suitable for large-scale industrial production, can produce high-purity aryl(3-sulfonylbenzofuran-2- base) ketone compounds.
附图说明Description of drawings
图1为芳基(3-砜基苯并呋喃-2-基)甲酮衍生物3a的1H-NMR的核磁共振谱;Fig. 1 is the nuclear magnetic resonance spectrum of 1H-NMR of aryl (3-sulfonylbenzofuran-2-yl)methanone derivative 3a;
图2为芳基(3-砜基苯并呋喃-2-基)甲酮衍生物3a的13C-NMR的核磁共振谱;Fig. 2 is the nuclear magnetic resonance spectrum of 13C-NMR of aryl (3-sulfonylbenzofuran-2-yl)methanone derivative 3a;
图3为芳基(3-砜基苯并呋喃-2-基)甲酮衍生物3b的1H-NMR的核磁共振谱;Fig. 3 is the nuclear magnetic resonance spectrum of 1H-NMR of aryl (3-sulfonylbenzofuran-2-yl)methanone derivative 3b;
图4为芳基(3-砜基苯并呋喃-2-基)甲酮衍生物3b的13C-NMR的核磁共振谱;Fig. 4 is the nuclear magnetic resonance spectrum of 13C-NMR of aryl(3-sulfonylbenzofuran-2-yl)methanone derivative 3b;
图5为芳基(3-砜基苯并呋喃-2-基)甲酮衍生物3c的1H-NMR的核磁共振谱;Fig. 5 is the nuclear magnetic resonance spectrum of 1H-NMR of aryl (3-sulfonylbenzofuran-2-yl)methanone derivative 3c;
图6为芳基(3-砜基苯并呋喃-2-基)甲酮衍生物3c的13C-NMR的核磁共振谱;Fig. 6 is the nuclear magnetic resonance spectrum of 13C-NMR of aryl(3-sulfonylbenzofuran-2-yl)methanone derivative 3c;
图7为芳基(3-砜基苯并呋喃-2-基)甲酮衍生物3d的1H-NMR的核磁共振谱;Fig. 7 is the nuclear magnetic resonance spectrum of 1H-NMR of aryl(3-sulfonylbenzofuran-2-yl)methanone derivative 3d;
图8为芳基(3-砜基苯并呋喃-2-基)甲酮衍生物3d的13C-NMR的核磁共振谱;Fig. 8 is the nuclear magnetic resonance spectrum of 13C-NMR of aryl(3-sulfonylbenzofuran-2-yl)methanone derivative 3d;
图9为芳基(3-砜基苯并呋喃-2-基)甲酮衍生物3e的1H-NMR的核磁共振谱;Fig. 9 is the nuclear magnetic resonance spectrum of 1H-NMR of aryl (3-sulfonylbenzofuran-2-yl)methanone derivative 3e;
图10为芳基(3-砜基苯并呋喃-2-基)甲酮衍生物3e的13C-NMR的核磁共振谱。Fig. 10 is a nuclear magnetic resonance spectrum of 13C-NMR of an aryl(3-sulfonylbenzofuran-2-yl)methanone derivative 3e.
具体实施方式Detailed ways
下面结合附图和具体实施例对本发明作进一步详细说明。The present invention will be further described in detail below with reference to the accompanying drawings and specific embodiments.
实施例1:苯基(3-砜基苯并呋喃-2-基)甲酮衍生物3a的制备Example 1: Preparation of phenyl(3-sulfonylbenzofuran-2-yl)methanone derivative 3a
向带有磁力搅拌装置的25mL耐压管中加入CH3CN(4mL)、2-(1-羟基-3-芳基丙-2-炔-1-基)苯酚1a(0.224g,1.0mmol)和对甲苯磺酰基甲基异氰TsCH2NC2a(0.293g,1.5mmol),加入碘化亚铜(0.019g,0.1mol)搅拌均匀后,将其放入80℃油浴中继续搅拌。TLC检测底物消失,反应结束。将反应液倾入饱和氯化钠水溶液中(10mL),用二氯甲烷(3×10mL)萃取,合并有机相,然后用水(3×10mL)反洗有机相,经过无水氯化钙干燥、抽虑、减压蒸馏等步骤得到粘稠的固体,最后经过硅胶柱层析(洗脱液为V石油醚:V乙酸乙酯=4:1)得到黄色固体,经过NMR、MS证实为苯基(3-砜基苯并呋喃-2-基)甲酮衍生物3a,其收率为91%。To a 25 mL pressure tube with a magnetic stirring device was added CH 3 CN (4 mL), 2-(1-hydroxy-3-arylprop-2-yn-1-yl)phenol 1a (0.224 g, 1.0 mmol) and p-toluenesulfonyl methyl isocyanide TsCH 2 NC2a (0.293 g, 1.5 mmol), cuprous iodide (0.019 g, 0.1 mol) was added and stirred evenly, then it was placed in an 80° C. oil bath to continue stirring. TLC detected the disappearance of the substrate and the reaction ended. The reaction solution was poured into saturated aqueous sodium chloride solution (10 mL), extracted with dichloromethane (3×10 mL), the organic phases were combined, and then the organic phase was backwashed with water (3×10 mL), dried over anhydrous calcium chloride, Steps such as extraction and distillation under reduced pressure obtain a viscous solid, and finally through silica gel column chromatography (eluent is V petroleum ether : V ethyl acetate =4:1) to obtain a yellow solid, which is confirmed to be phenyl through NMR and MS (3-sulfonylbenzofuran-2-yl)methanone derivative 3a in 91% yield.
谱图解析数据3a:Spectrogram analysis data 3a:
黄色固体,m.p.115-116℃;1H NMR(CDCl3,400MHz):δH 8.22-8.20(m,1H,ArH),8.14-8.12(m,2H,ArH),7.95-7.92(m,2H,ArH),7.69-7.65(m,1H,ArH),7.57-7.46(m,5H,ArH),7.34(d,J=8.0Hz,2H,ArH),2.41(s,3H,CH3)(图1);13C NMR(CDCl3,100MHz):δC184.7,153.7,152.7,144.8,138.1,135.6,134.6,130.3,129.8,128.8,128.2,127.8,125.54,125.45,123.7,122.3,112.4,21.7(图2);HRMS(ESI-TOF,m/z):Calcd for C22H17O4S[M+H]+:377.0842,found 377.0839.Yellow solid, mp 115-116°C; 1 H NMR (CDCl 3 , 400 MHz): δ H 8.22-8.20 (m, 1H, ArH), 8.14-8.12 (m, 2H, ArH), 7.95-7.92 (m, 2H, ArH), 7.69-7.65(m, 1H, ArH), 7.57-7.46(m, 5H, ArH), 7.34(d, J=8.0Hz, 2H, ArH), 2.41(s, 3H, CH 3 ) (Fig. 1); 13 C NMR (CDCl 3 , 100MHz): δ C 184.7, 153.7, 152.7, 144.8, 138.1, 135.6, 134.6, 130.3, 129.8, 128.8, 128.2, 127.8, 125.54, 125.45, 123.7, 122.3, 112. (Fig. 2); HRMS (ESI-TOF, m/z): Calcd for C 22 H 17 O 4 S[M+H] + : 377.0842, found 377.0839.
实施例2:与实施例1不同的是,有机溶剂选自1,2-二氯乙烷,其收率为83%。Example 2: Different from Example 1, the organic solvent was selected from 1,2-dichloroethane, and its yield was 83%.
实施例3:与实施例1不同的是,有机溶剂选自1,4-二氧六环,其收率为75%。Example 3: Different from Example 1, the organic solvent was selected from 1,4-dioxane, and its yield was 75%.
实施例4:与实施例1不同的是,有机溶剂选自N,N-二甲基甲酰胺,其收率为87%。Example 4: Different from Example 1, the organic solvent was selected from N,N-dimethylformamide, and the yield was 87%.
实施例5:与实施例1不同的是,有机溶剂选自二甲基亚砜,其收率为84%。Example 5: Different from Example 1, the organic solvent was selected from dimethyl sulfoxide, and its yield was 84%.
实施例6:与实施例1不同的是,有机溶剂选自甲苯,其收率为82%。Example 6: Different from Example 1, the organic solvent was selected from toluene, and its yield was 82%.
实施例7:与实施例1不同的是,反应温度为60℃,其收率为77%。Example 7: Different from Example 1, the reaction temperature was 60°C, and the yield was 77%.
实施例8:与实施例1不同的是,反应温度为100℃,其收率为88%。Example 8: Different from Example 1, the reaction temperature was 100°C, and the yield was 88%.
实施例9:Example 9:
用1b代替实施例1中的1a,其他条件同实施例1,其收率为87%。Substitute 1b for 1a in Example 1, other conditions are the same as in Example 1, and the yield is 87%.
谱图解析数据3b:Spectrogram analysis data 3b:
黄色固体,m.p.112-113℃;1H NMR(CDCl3,400MHz):δH.8.12(d,J=8.0Hz,2H,ArH),7.98-7.93(m,3H,ArH),7.70-7.66(m,1H,ArH),7.55-7.51(m,2H,ArH),7.43-7.38(m,1H,ArH),7.35(d,J=8.0Hz,2H,ArH),7.26-7.21(m,1H,ArH),2.40(s,3H,CH3)(图3);13CNMR(CDCl3,100MHz):δC 184.2,153.5,147.9(d,JF-C=251.9Hz),145.1,141.1(d,JF-C=12.5Hz),137.6,135.2,134.8,130.3,129.8,128.8,128.2,126.8(d,JF-C=2.2Hz),126.3(d,JF-C=5.7Hz),125.1(d,JF-C=2.2Hz),117.7(d,JF-C=4.6Hz),113.8(d,JF-C=15.5Hz),21.6(图4);HRMS(ESI-TOF,m/z):Calcd for C22H16FO4S[M+H]+:395.0748,found 395.0752.Yellow solid, mp 112-113°C; 1 H NMR (CDCl 3 , 400 MHz): δ H .8.12 (d, J=8.0 Hz, 2H, ArH), 7.98-7.93 (m, 3H, ArH), 7.70-7.66 ( m,1H,ArH),7.55-7.51(m,2H,ArH),7.43-7.38(m,1H,ArH),7.35(d,J=8.0Hz,2H,ArH),7.26-7.21(m,1H , ArH), 2.40 (s, 3H, CH 3 ) (Fig. 3); 13 CNMR (CDCl 3 , 100 MHz): δ C 184.2, 153.5, 147.9 (d, J FC =251.9 Hz), 145.1, 141.1 (d, JFC = 12.5Hz), 137.6, 135.2, 134.8, 130.3, 129.8, 128.8, 128.2, 126.8(d, JFC = 2.2Hz), 126.3(d, JFC = 5.7Hz), 125.1(d, JFC = 2.2 Hz), 117.7 (d, J FC = 4.6 Hz), 113.8 (d, J FC = 15.5 Hz), 21.6 (Fig. 4); HRMS (ESI-TOF, m/z): Calcd for C 22 H 16 FO 4 S[M+H] + :395.0748, found 395.0752.
实施例10:Example 10:
用1c代替实施例1中的1a,其他条件同实施例1,其收率为79%。Substitute 1c for 1a in Example 1, other conditions are the same as in Example 1, and the yield is 79%.
谱图解析数据3c:Spectrogram analysis data 3c:
黄色固体,m.p.102-103℃;1H NMR(CDCl3,400MHz):δH 8.11(d,J=8.0Hz,2H,ArH),8.00(d,J=8.0Hz,1H,ArH),7.96-7.04(m,2H,ArH),7.69-7.64(m,1H,ArH),7.54-7.50(m,2H,ArH),7.38-7.28(m,4H,ArH),2.47(s,3H,CH3),2.39(s,3H,CH3)(图5);13C NMR(CDCl3,100MHz):δC 184.9,152.9,152.4,144.7,138.1,135.6,134.5,130.3,129.7,128.7,128.5,128.1,125.6,125.3,123.1,122.7,119.4,21.6,14.8(图6);HRMS(ESI-TOF,m/z):Calcd for C23H19O4S[M+H]+:391.0999,found 391.0986.Yellow solid, mp 102-103°C; 1 H NMR (CDCl 3 , 400 MHz): δ H 8.11 (d, J=8.0 Hz, 2H, ArH), 8.00 (d, J=8.0 Hz, 1H, ArH), 7.96- 7.04(m, 2H, ArH), 7.69-7.64(m, 1H, ArH), 7.54-7.50(m, 2H, ArH), 7.38-7.28(m, 4H, ArH), 2.47(s, 3H, CH 3 The _ _ _ 128.1, 125.6, 125.3, 123.1, 122.7, 119.4, 21.6, 14.8 (Fig. 6); HRMS (ESI-TOF, m/z): Calcd for C 23 H 19 O 4 S[M+H] + :391.0999, found 391.0986.
实施例11:Example 11:
用1d代替实施例1中的1a,其他条件同实施例1,其收率为81%。Substitute 1d for 1a in Example 1, other conditions are the same as in Example 1, and the yield is 81%.
谱图解析数据3d:Spectrogram analysis data 3d:
白色固体,m.p.121-122℃;1H NMR(CDCl3,400MHz):δH 8.11(d,J=8.4Hz,2H,ArH),7.96-7.04(m,2H,ArH),7.74(dd,J=8.0Hz and 0.8Hz,1H,ArH),7.68-7.63(m,1H,ArH),7.53-7.49(m,2H,ArH),7.40-7.32(m,3H,ArH),6.97(dd,J=8.0Hz and 0.8Hz,1H,ArH),3.96(s,3H,OCH3),2.40(s,3H,CH3)(图7);13C NMR(CDCl3,100MHz):δC 184.6,152.9,145.8,144.8,143.4,138.0,135.5,134.5,130.3,129.7,128.7,128.1,126.3,125.4,125.2,113.6,109.2,56.2,21.6(图8);HRMS(ESI-TOF,m/z):Calcd for C23H19O5S[M+H]+:407.0948,found 407.0952.White solid, mp 121-122°C; 1 H NMR (CDCl 3 , 400 MHz): δ H 8.11 (d, J=8.4 Hz, 2H, ArH), 7.96-7.04 (m, 2H, ArH), 7.74 (dd, J =8.0Hz and 0.8Hz,1H,ArH),7.68-7.63(m,1H,ArH),7.53-7.49(m,2H,ArH),7.40-7.32(m,3H,ArH),6.97(dd,J = 8.0 Hz and 0.8 Hz, 1H, ArH), 3.96 (s, 3H, OCH 3 ), 2.40 (s, 3H, CH 3 ) (Fig. 7); 13 C NMR (CDCl 3 , 100 MHz): δ C 184.6, HRMS (ESI-TOF, m/z) :Calcd for C 23 H 19 O 5 S[M+H] + :407.0948,found 407.0952.
实施例12:Example 12:
用1e代替实施例1中的1a,其他条件同实施例1,其收率为74%。Substitute 1e for 1a in Example 1, other conditions are the same as in Example 1, and the yield is 74%.
谱图解析数据3e:Spectrogram analysis data 3e:
白色固体,m.p.132-133℃;1H NMR(CDCl3,400MHz):δH 8.15(d,J=8.8Hz,1H,ArH),8.12-8.09(m,2H,ArH),7.93-7.91(m,2H,ArH),7.70-7.66(m,1H,ArH),7.58(d,J=2.0Hz,1H,ArH),7.55-7.51(m,2H,ArH),7.47(dd,J=8.4Hz and 2.0Hz,1H,ArH),7.35(d,J=8.4Hz,2H,ArH),2.41(s,3H,CH3)(图9);13C NMR(CDCl3,100MHz):δC 184.1,153.5,153.0,145.1,137.8,135.3,134.7,134.0,130.2,129.8,128.8,128.2,126.5,125.6,122.9,122.4,112.8,21.7(图10);HRMS(ESI-TOF,m/z):Calcd for C22H16ClO4S[M+H]+:411.0452,found 411.0461.White solid, mp 132-133°C; 1 H NMR (CDCl 3 , 400 MHz): δ H 8.15 (d, J=8.8 Hz, 1 H, ArH), 8.12-8.09 (m, 2H, ArH), 7.93-7.91 (m ,2H,ArH),7.70-7.66(m,1H,ArH),7.58(d,J=2.0Hz,1H,ArH),7.55-7.51(m,2H,ArH),7.47(dd,J=8.4Hz and 2.0 Hz, 1H, ArH), 7.35 (d, J=8.4 Hz, 2H, ArH), 2.41 (s, 3H, CH 3 ) (Fig. 9); 13 C NMR (CDCl 3 , 100 MHz): δ C 184.1 ,153.5,153.0,145.1,137.8,135.3,134.7,134.0,130.2,129.8,128.8,128.2,126.5,125.6,122.9,122.4,112.8,21.7(Figure 10); HRMS(ESI-TOF,m/z): Calcd for C 22 H 16 ClO 4 S[M+H] + : 411.0452, found 411.0461.
实施例13:Example 13:
用1f代替实施例1中的1a,其他条件同实施例1,其收率为75%。Substitute 1f for 1a in Example 1, other conditions are the same as in Example 1, and the yield is 75%.
谱图解析数据3f:Spectrogram analysis data 3f:
白色固体,m.p.113-114℃;1H NMR(CDCl3,400MHz):δH 8.22-8.20(m,1H,ArH),8.12(d,J=8.4Hz,2H,ArH),8.01-7.96(m,2H,ArH),7.58-7.46(m,3HV),7.34(d,J=8.0Hz,2H,ArH),7.22-7.17(m,2H,ArH),2.40(s,3H,CH3);13C NMR(CDCl3,100MHz):δC 183.0,166.6(d,JF-C=256.6Hz),153.7,152.3,144.9,138.0,133.0(d,JF-C=9.6Hz),132.0(d,JF-C=2.7Hz),129.7,128.1,127.9,125.6,123.6,122.3(d,JF-C=22.3Hz),116.1,112.3,21.6;HRMS(ESI-TOF,m/z):Calcd for C22H16FO4S[M+H]+:395.0748,found 395.0738.White solid, mp 113-114°C; 1 H NMR (CDCl 3 , 400 MHz): δ H 8.22-8.20 (m, 1H, ArH), 8.12 (d, J=8.4 Hz, 2H, ArH), 8.01-7.96 (m , 2H, ArH), 7.58-7.46 (m, 3HV), 7.34 (d, J=8.0Hz, 2H, ArH), 7.22-7.17 (m, 2H, ArH), 2.40 (s, 3H, CH 3 ); 13 C NMR (CDCl 3 , 100 MHz): δ C 183.0, 166.6 (d, J FC = 256.6 Hz), 153.7, 152.3, 144.9, 138.0, 133.0 (d, J FC = 9.6 Hz), 132.0 (d, J FC = 9.6 Hz) = 2.7Hz), 129.7, 128.1, 127.9, 125.6, 123.6, 122.3 (d, J FC = 22.3 Hz), 116.1, 112.3, 21.6; HRMS (ESI-TOF, m/z): Calcd for C 22 H 16 FO 4 S[M+H] + :395.0748, found 395.0738.
实施例14:Example 14:
用1g代替实施例1中的1a,其他条件同实施例1,其收率为79%。Substitute 1g for 1a in Example 1, other conditions are the same as in Example 1, and the yield is 79%.
谱图解析数据3g:Spectrogram analysis data 3g:
白色固体,m.p.137-138℃;1H NMR(CDCl3,400MHz):δH 8.22(dd,J=6.8Hz and1.6Hz,1H,ArH),8.13-8.11(m,2H,ArH),7.91-7.87(m,2H,ArH),7.58-7.46(m,5H,ArH),7.34(d,J=8.0Hz,2H,ArH),2.40(s,3H,CH3);13C NMR(CDCl3,100MHz):δC 183.3,153.7,152.0,144.9,141.1,137.9,133.9,131.5,129.7,129.1,128.1,128.0,125.8,125.6,123.6,122.3,112.3,21.6;HRMS(ESI-TOF,m/z):Calcd for C22H16ClO4S[M+H]+:411.0452,found 411.0451.White solid, mp 137-138°C; 1 H NMR (CDCl 3 , 400 MHz): δ H 8.22 (dd, J=6.8 Hz and 1.6 Hz, 1H, ArH), 8.13-8.11 (m, 2H, ArH), 7.91- 7.87 (m, 2H, ArH), 7.58-7.46 (m, 5H, ArH), 7.34 (d, J=8.0Hz, 2H, ArH), 2.40 (s, 3H, CH 3 ); 13 C NMR (CDCl 3 ) , 100MHz): δ C 183.3, 153.7, 152.0, 144.9, 141.1, 137.9, 133.9, 131.5, 129.7, 129.1, 128.1, 128.0, 125.8, 125.6, 123.6, 122.3, 112.3, 21.6; HRMS (ESI-TOF z): Calcd for C 22 H 16 ClO 4 S[M+H] + : 411.0452, found 411.0451.
实施例15:Example 15:
用1h代替实施例1中的1a,其他条件同实施例1,其收率为82%。Substitute 1h for 1a in Example 1, other conditions are the same as in Example 1, and the yield is 82%.
谱图解析数据3h:Spectrogram analysis data 3h:
白色固体,m.p.141-142℃;1H NMR(CDCl3,400MHz):δH 8.19(dd,J=6.4Hz and2.0Hz,1H,ArH),8.12(d,J=8.4Hz,2H,ArH),7.84(d,J=8.4Hz,2H,ArH),7.56-7.44(m,3H,ArH),7.34-7.31(m,4H,ArH),2.46(m,3H,CH3),2.40(s,3H,CH3);13C NMR(CDCl3,100MHz):δC184.3,153.6,153.1,145.9,144.7,138.1,133.1,130.4,129.7,129.5,128.1,127.6,125.4,125.0,123.6,122.1,112.3,21.9,21.6;HRMS(ESI-TOF,m/z):Calcd for C23H19O4S[M+H]+:391.0999,found 391.0982.White solid, mp 141-142°C; 1 H NMR (CDCl 3 , 400 MHz): δ H 8.19 (dd, J=6.4 Hz and 2.0 Hz, 1H, ArH), 8.12 (d, J=8.4 Hz, 2H, ArH) , 7.84(d, J=8.4Hz, 2H, ArH), 7.56-7.44(m, 3H, ArH), 7.34-7.31(m, 4H, ArH), 2.46(m, 3H, CH 3 ), 2.40(s , 3H, CH 3 ); 13 C NMR (CDCl 3 , 100 MHz): δ C 184.3, 153.6, 153.1, 145.9, 144.7, 138.1, 133.1, 130.4, 129.7, 129.5, 128.1, 127.6, 125.4, 125.0, 123.6, 122.1 , 112.3, 21.9, 21.6; HRMS(ESI-TOF, m/z): Calcd for C 23 H 19 O 4 S[M+H] + : 391.0999, found 391.0982.
实施例16:Example 16:
用1i代替实施例1中的1a,其他条件同实施例1,其收率为81%。Substitute 1i for 1a in Example 1, other conditions are the same as in Example 1, and the yield is 81%.
谱图解析数据3i:Spectrogram analysis data 3i:
白色固体,m.p.151-152℃;1H NMR(CDCl3,400MHz):δH 8.17(dd,J=6.8Hz and2.8Hz,1H,ArH),8.12(d,J=8.0Hz,2H,ArH),7.93(d,J=8.8Hz,2H,ArH),7.55-7.43(m,3H,ArH),7.33(d,J=8.0Hz,2H,ArH),6.98(d,J=8.8Hz,2H,ArH),3.90(m,3H,OCH3),2.39(s,3H,CH3);13C NMR(CDCl3,100MHz):δC 183.1,164.8,153.6,153.4,144.7,138.1,132.8,129.7,128.6,128.1,127.5,125.4,124.5,123.6,122.0,114.1,112.2,55.6,21.6;HRMS(ESI-TOF,m/z):Calcd for C23H19O5S[M+H]+:407.0948,found 407.0953.White solid, mp 151-152°C; 1 H NMR (CDCl 3 , 400 MHz): δ H 8.17 (dd, J=6.8 Hz and 2.8 Hz, 1H, ArH), 8.12 (d, J=8.0 Hz, 2H, ArH) ,7.93(d,J=8.8Hz,2H,ArH),7.55-7.43(m,3H,ArH),7.33(d,J=8.0Hz,2H,ArH),6.98(d,J=8.8Hz,2H , ArH), 3.90 (m, 3H, OCH 3 ), 2.39 (s, 3H, CH 3 ); 13 C NMR (CDCl 3 , 100MHz): δ C 183.1, 164.8, 153.6, 153.4, 144.7, 138.1, 132.8, 129.7, 128.6, 128.1, 127.5, 125.4, 124.5, 123.6, 122.0, 114.1, 112.2, 55.6, 21.6; HRMS(ESI-TOF, m/z): Calcd for C 23 H 19 O 5 S[M+H] + :407.0948,found 407.0953.
实施例17:Example 17:
用1j代替实施例1中的1a,其他条件同实施例1,其收率为87%。Substitute 1j for 1a in Example 1, other conditions are the same as in Example 1, and the yield is 87%.
谱图解析数据3j:Spectrogram analysis data 3j:
白色固体,m.p.144-145℃;1H NMR(CDCl3,400MHz):δH 8.19(dd,J=6.4Hz and2.0Hz,1H,ArH),8.13(d,J=8.4Hz,2H,ArH),7.87-7.85(m,2H,ArH),7.55-7.44(m,3H,ArH),7.35-7.32(m,4H,ArH),2.75(q,J=7.6Hz,2H,CH2),2.40(s,3H,CH3),1.28(t,J=7.6Hz,3H,CH3);13C NMR(CDCl3,100MHz):δC 184.4,153.7,153.2,152.0,144.8,138.2,133.4,130.6,129.8,128.4,128.2,127.7,125.5,125.0,123.7,122.2,112.3,29.2,21.7,15.1;HRMS(ESI-TOF,m/z):Calcd for C24H21O4S[M+H]+:405.1155,found 405.1161.White solid, mp 144-145°C; 1 H NMR (CDCl 3 , 400 MHz): δ H 8.19 (dd, J=6.4 Hz and 2.0 Hz, 1H, ArH), 8.13 (d, J=8.4 Hz, 2H, ArH) , 7.87-7.85 (m, 2H, ArH), 7.55-7.44 (m, 3H, ArH), 7.35-7.32 (m, 4H, ArH), 2.75 (q, J=7.6Hz, 2H, CH 2 ), 2.40 (s, 3H, CH 3 ), 1.28 (t, J=7.6 Hz, 3H, CH 3 ); 13 C NMR (CDCl 3 , 100 MHz): δ C 184.4, 153.7, 153.2, 152.0, 144.8, 138.2, 133.4, 130.6, 129.8, 128.4, 128.2, 127.7, 125.5, 125.0, 123.7, 122.2, 112.3, 29.2, 21.7, 15.1; HRMS(ESI-TOF, m/z): Calcd for C 24 H 21 O 4 S[M+H ] + :405.1155,found 405.1161.
实施例18:Example 18:
用1k代替实施例1中的1a,其他条件同实施例1,其收率为81%。Substitute 1k for 1a in Example 1, other conditions are the same as in Example 1, and the yield is 81%.
谱图解析数据3k:Spectrogram analysis data 3k:
白色固体,m.p.145-147℃;1H NMR(CDCl3,400MHz):δH 8.16(dd,J=6.0Hz and1.6Hz,1H,ArH),8.12(d,J=8.4Hz,2H,ArH),7.93-7.89(m,2H,ArH),7.55-7.52(m,1H,ArH),7.50-7.43(m,2H,ArH),7.32(d,J=8.4Hz,2H,ArH),6.98-6.94(m,2H,ArH),4.13(q,J=6.8Hz,2H,CH2),2.39(s,3H,CH3),1.45(t,J=7.2Hz,3H,CH3);13C NMR(CDCl3,100MHz):δC183.2,164.4,153.7,153.6,144.8,138.3,132.9,129.8,128.5,128.2,127.6,125.5,124.5,123.7,122.1,114.6,112.4,64.1,21.7,14.7;HRMS(ESI-TOF,m/z):Calcd forC24H21O5S[M+H]+:421.1104,found 421.1121.White solid, mp 145-147°C; 1 H NMR (CDCl 3 , 400 MHz): δ H 8.16 (dd, J=6.0 Hz and 1.6 Hz, 1H, ArH), 8.12 (d, J=8.4 Hz, 2H, ArH) ,7.93-7.89(m,2H,ArH),7.55-7.52(m,1H,ArH),7.50-7.43(m,2H,ArH),7.32(d,J=8.4Hz,2H,ArH),6.98- 6.94 (m, 2H, ArH), 4.13 (q, J=6.8 Hz, 2H, CH 2 ), 2.39 (s, 3H, CH 3 ), 1.45 (t, J=7.2 Hz, 3H, CH 3 ); 13 C NMR (CDCl 3 , 100MHz): δ C 183.2, 164.4, 153.7, 153.6, 144.8, 138.3, 132.9, 129.8, 128.5, 128.2, 127.6, 125.5, 124.5, 123.7, 122.1, 114.6, 112.4, 64.1, 212.4, 64.1 ;HRMS(ESI-TOF,m/z):Calcd forC 24 H 21 O 5 S[M+H] + : 421.1104, found 421.1121.
实施例19:Example 19:
用1l代替实施例1中的1a,其他条件同实施例1,其收率为75%。Substitute 11 for 1a in Example 1, other conditions are the same as in Example 1, and the yield is 75%.
谱图解析数据3l:Spectrogram analysis data 3l:
白色固体,m.p.123-124℃;1H NMR(CDCl3,400MHz):δH 8.25-8.22(m,1H,ArH),8.14-8.12(m,2H,ArH),7.73-7.71(m,1H,ArH),7.68-7.65(m,1H,ArH),7.58-7.47(m,4H,ArH),7.39-7.34(m,3H,ArH),2.41(s,3H,CH3);13C NMR(CDCl3,100MHz):δC 183.2(d,JF-C=2.6Hz),162.6(d,JF-C=247.2Hz),153.7,151.8,144.9,137.9,137.4(d,JF-C=6.8Hz),130.5(d,JF-C=7.6Hz),129.8,128.2,128.1,126.2(d,JF-C=3.1Hz),126.1,125.7,123.6,122.3,121.6(d,JF-C=21.4Hz),116.6(d,JF-C=22.8Hz),112.4,21.7;HRMS(ESI-TOF,m/z):Calcd for C22H16FO4S[M+H]+:395.0748,found 395.0752.White solid, mp 123-124°C; 1 H NMR (CDCl 3 , 400 MHz): δ H 8.25-8.22 (m, 1H, ArH), 8.14-8.12 (m, 2H, ArH), 7.73-7.71 (m, 1H, ArH), 7.68-7.65 (m, 1H, ArH), 7.58-7.47 (m, 4H, ArH), 7.39-7.34 (m, 3H, ArH), 2.41 (s, 3H, CH 3 ); 13 C NMR ( CDCl 3 , 100MHz): δ C 183.2 (d, J FC = 2.6 Hz), 162.6 (d, J FC = 247.2 Hz), 153.7, 151.8, 144.9, 137.9, 137.4 (d, J FC = 6.8 Hz), 130.5 (d, JFC = 7.6Hz), 129.8, 128.2, 128.1, 126.2 (d, JFC = 3.1Hz), 126.1, 125.7, 123.6, 122.3, 121.6 (d, JFC = 21.4Hz), 116.6(d, J FC = 22.8Hz), 112.4, 21.7; HRMS (ESI-TOF, m/z): Calcd for C 22 H 16 FO 4 S[M+H] + : 395.0748, found 395.0752.
实施例20:Example 20:
用1m代替实施例1中的1a,其他条件同实施例1,其收率为85%。Substitute 1m for 1a in Example 1, other conditions are the same as in Example 1, and the yield is 85%.
谱图解析数据3m:Spectrogram analysis data 3m:
白色固体,m.p.152-153℃;1H-NMR(400MHz,CDCl3)δ8.32(s,1H),8.24-8.22(m,1H),8.10(d,J=8.0Hz 2H),8.06(dd,J=8.4Hz and 2.0Hz,1H),7.95(d,J=8.8Hz,1H),7.91-7.87(m,2H),7.66-7.62(m,1H),7.59-7.47(m,4H),7.30(d,J=8.4Hz,2H),2.38(s,3H);13C-NMR(CDCl3,100MHz)δ184.7,153.8,153.0,144.8,138.1,136.2,133.5,133.0,132.2,129.9,129.7,129.4,128.8,128.1,127.9,127.7,127.0,125.5,125.2,124.4,123.7,122.1,112.4,21.6.;HRMS(ESI-TOF)m/z calculated for C26H19O4S[M+H]+:427.0999found:427.0992.White solid, mp 152-153°C; 1 H-NMR (400 MHz, CDCl 3 ) δ 8.32 (s, 1H), 8.24-8.22 (m, 1H), 8.10 (d, J=8.0 Hz 2H), 8.06 (dd ,J=8.4Hz and 2.0Hz,1H),7.95(d,J=8.8Hz,1H),7.91-7.87(m,2H),7.66-7.62(m,1H),7.59-7.47(m,4H) , 7.30(d, J=8.4Hz, 2H), 2.38(s, 3H); 13 C-NMR (CDCl 3 , 100MHz) δ 184.7, 153.8, 153.0, 144.8, 138.1, 136.2, 133.5, 133.0, 132.2, 129.9, 129.7,129.4,128.8,128.1,127.9,127.7,127.0,125.5,125.2,124.4,123.7,122.1,112.4,21.6.; HRMS(ESI-TOF)m/z calculated for C 26 H 19 O 4 S[M+ H] + :427.0999found:427.0992.
实施例21:Example 21:
用1n代替实施例1中的1a,其他条件同实施例1,其收率为74%。1a in Example 1 was replaced by 1n, and other conditions were the same as in Example 1, and the yield was 74%.
谱图解析数据3n:Spectrogram analysis data 3n:
白色固体,m.p.125-126℃;1H-NMR(400MHz,CDCl3)δ8.34(d,J=7.6Hz,1H),8.18(d,J=8.0Hz,2H),7.97(d,J=4.0Hz,1H),7.83(d,J=4.4Hz,1H),7.61-7.48(m,3H),7.34(d,J=8.0Hz,2H),7.23-7.20(m,1H),2.40(s,3H);13C-NMR(CDCl3,100MHz)δ174.9,153.4,151.2,144.8,142.1,138.2,136.4,136.2,129.6,128.6,128.3,128.3,126.2,125.6,124.1,122.9,112.3,21.7;HRMS(ESI-TOF)m/z calculated for C20H15O4S2[M+H]+:383.0406 found:383.0411.White solid, mp 125-126°C; 1 H-NMR (400MHz, CDCl 3 ) δ 8.34 (d, J=7.6 Hz, 1H), 8.18 (d, J=8.0 Hz, 2H), 7.97 (d, J= 4.0Hz,1H),7.83(d,J=4.4Hz,1H),7.61-7.48(m,3H),7.34(d,J=8.0Hz,2H),7.23-7.20(m,1H),2.40( s, 3H); 13 C-NMR (CDCl 3 , 100MHz) δ 174.9, 153.4, 151.2, 144.8, 142.1, 138.2, 136.4, 136.2, 129.6, 128.6, 128.3, 128.3, 126.2, 125.6, 124.1, 122.9, 112.3. ;HRMS(ESI-TOF)m/z calculated for C 20 H 15 O 4 S 2 [M+H] + :383.0406 found:383.0411.
Claims (7)
Priority Applications (1)
Application Number | Priority Date | Filing Date | Title |
---|---|---|---|
CN202010512204.9A CN111592509B (en) | 2020-06-08 | 2020-06-08 | Method for synthesizing aryl (3-sulfuryl benzofuran-2-yl) ketone compound by copper catalysis |
Applications Claiming Priority (1)
Application Number | Priority Date | Filing Date | Title |
---|---|---|---|
CN202010512204.9A CN111592509B (en) | 2020-06-08 | 2020-06-08 | Method for synthesizing aryl (3-sulfuryl benzofuran-2-yl) ketone compound by copper catalysis |
Publications (2)
Publication Number | Publication Date |
---|---|
CN111592509A true CN111592509A (en) | 2020-08-28 |
CN111592509B CN111592509B (en) | 2022-11-22 |
Family
ID=72184763
Family Applications (1)
Application Number | Title | Priority Date | Filing Date |
---|---|---|---|
CN202010512204.9A Active CN111592509B (en) | 2020-06-08 | 2020-06-08 | Method for synthesizing aryl (3-sulfuryl benzofuran-2-yl) ketone compound by copper catalysis |
Country Status (1)
Country | Link |
---|---|
CN (1) | CN111592509B (en) |
Cited By (1)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
CN113372219A (en) * | 2021-05-17 | 2021-09-10 | 三峡大学 | Method for preparing ethynylnaphthalene derivative by [4+2] cyclization reaction with water as solvent |
Citations (8)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
CN102391260A (en) * | 2011-09-29 | 2012-03-28 | 上海交通大学 | 3-ketone-6-substituted-benzofuran compound as well as preparation method and application thereof |
CN106045952A (en) * | 2016-07-05 | 2016-10-26 | 华南理工大学 | Synthesizing method of benzofuranone compound containing sulfonyl |
CN106883132A (en) * | 2017-01-18 | 2017-06-23 | 中山大学 | With N, the substitution hydrazides of N bis- is the copper catalysis C N coupling methods of part to one kind |
CN108409747A (en) * | 2018-02-28 | 2018-08-17 | 华南理工大学 | A kind of synthetic method of 2- aminoquinolines and dihydrofuran class compound |
CN109180653A (en) * | 2018-10-16 | 2019-01-11 | 江苏师范大学 | A kind of copper catalysis prepares benzofuran-azoles method |
CN109180520A (en) * | 2018-10-16 | 2019-01-11 | 江苏师范大学 | A kind of method that silver catalyzes and synthesizes functionalization benzo compound of fluorene class |
CN109384753A (en) * | 2017-08-08 | 2019-02-26 | 沈阳药科大学 | A kind of synthetic method of 2- phenyl -3- methyl-benzofuran compounds |
CN110511197A (en) * | 2019-08-09 | 2019-11-29 | 华南师范大学 | A kind of N-furanone arylsulfonylhydrazone compound and its synthesis method and application |
-
2020
- 2020-06-08 CN CN202010512204.9A patent/CN111592509B/en active Active
Patent Citations (8)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
CN102391260A (en) * | 2011-09-29 | 2012-03-28 | 上海交通大学 | 3-ketone-6-substituted-benzofuran compound as well as preparation method and application thereof |
CN106045952A (en) * | 2016-07-05 | 2016-10-26 | 华南理工大学 | Synthesizing method of benzofuranone compound containing sulfonyl |
CN106883132A (en) * | 2017-01-18 | 2017-06-23 | 中山大学 | With N, the substitution hydrazides of N bis- is the copper catalysis C N coupling methods of part to one kind |
CN109384753A (en) * | 2017-08-08 | 2019-02-26 | 沈阳药科大学 | A kind of synthetic method of 2- phenyl -3- methyl-benzofuran compounds |
CN108409747A (en) * | 2018-02-28 | 2018-08-17 | 华南理工大学 | A kind of synthetic method of 2- aminoquinolines and dihydrofuran class compound |
CN109180653A (en) * | 2018-10-16 | 2019-01-11 | 江苏师范大学 | A kind of copper catalysis prepares benzofuran-azoles method |
CN109180520A (en) * | 2018-10-16 | 2019-01-11 | 江苏师范大学 | A kind of method that silver catalyzes and synthesizes functionalization benzo compound of fluorene class |
CN110511197A (en) * | 2019-08-09 | 2019-11-29 | 华南师范大学 | A kind of N-furanone arylsulfonylhydrazone compound and its synthesis method and application |
Non-Patent Citations (2)
Title |
---|
FAN-XIAO MENG等: "Lewis acid-catalyzed tandem cyclization of in situ generated o-quinone methides and arylsulfonyl hydrazides for a one-pot entry to 3-sulfonylbenzofurans", 《ORGANIC CHEMISTRY FRONTIERS》 * |
SHIN KAMIJO等: "Copper- or Phosphine-Catalyzed Reaction of Alkynes with Isocyanides. Regioselective Synthesis of Substituted Pyrroles Controlled by the Catalyst", 《J. AM. CHEM. SOC》 * |
Cited By (1)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
CN113372219A (en) * | 2021-05-17 | 2021-09-10 | 三峡大学 | Method for preparing ethynylnaphthalene derivative by [4+2] cyclization reaction with water as solvent |
Also Published As
Publication number | Publication date |
---|---|
CN111592509B (en) | 2022-11-22 |
Similar Documents
Publication | Publication Date | Title |
---|---|---|
Read et al. | Synthesis of phenanthridine derivatives by microwave-mediated cyclization of o-furyl (allylamino) arenes | |
CN109180653B (en) | A kind of method for preparing benzofuran-pyrrole compound by copper catalysis | |
CN103113308B (en) | A method for preparing dihydropyrimidinone derivatives | |
CN112812084B (en) | Synthetic method of benzofuran compound | |
CN114014805B (en) | Preparation method of trifluoromethylated 2,4-quinolinedione compounds | |
CN111592509B (en) | Method for synthesizing aryl (3-sulfuryl benzofuran-2-yl) ketone compound by copper catalysis | |
CN103435609A (en) | Copper-catalyzed synthetic method of imidazo[1,2-a]pyridine-3-formaldehyde compound | |
CN107540678A (en) | A kind of intramolecular intersects dehydrogenation coupling and prepares the cumarin simultaneously method of heteroaryl cyclics and its derivative | |
CN108892604B (en) | A kind of method for preparing halogenated benzo[b]fluorenone series compounds | |
CN113135852B (en) | A kind of preparation method of 4-aminoquinoline compound | |
CN113444107B (en) | Synthetic method and anticancer activity of succinimide spiro-fused sultams compound | |
CN112574225B (en) | Tetrahydrofuran dihydroquinoline compound and preparation method and application thereof | |
CN110294708B (en) | Preparation method of trifluoroethelenylphenanthridine and 3,4-dihydroisoquinoline derivatives | |
Duan et al. | NaH promoted one-pot tandem reactions of 3-(1-alkynyl) chromones to form 2-nitrogen-substituted xanthones | |
CN113264816A (en) | Spiro [ cyclopropane-1, 2' -indene ] -1',3' -diketone derivative and synthetic method thereof | |
CN112125891A (en) | N2Selective tetrahydrofuran/tetrahydrothiophene substituted triazole derivative and synthesis method and application thereof | |
KR102510279B1 (en) | Azulenopyridinone compounds and its preparation method | |
CN101284779B (en) | A kind of preparation method of (E)-4-(beta-bromovinyl)phenol ester | |
CN113321639B (en) | A kind of method for preparing polysubstituted isoquinolinone derivatives | |
CN114349684B (en) | Synthetic method of benzo [ c, d ] indole imine derivative | |
CN116283761B (en) | A 3-alkenyl ketone substituted quinoline-2-one and a green synthesis method thereof | |
CN108586457A (en) | A kind of indoles carbocyclic ring based on α hydrogen migration strategies of nitrogen-atoms goes aromatization synthetic method | |
CN112824388B (en) | Acrylic ketone derivative of norfloxacin and preparation method and application thereof | |
CN110028435B (en) | A kind of method for synthesizing 3-formate-2-pyrroline compounds | |
CN110467558B (en) | A kind of reaction method of nickel-catalyzed synthesis of 3-amino isoindolinone |
Legal Events
Date | Code | Title | Description |
---|---|---|---|
PB01 | Publication | ||
PB01 | Publication | ||
SE01 | Entry into force of request for substantive examination | ||
SE01 | Entry into force of request for substantive examination | ||
GR01 | Patent grant | ||
GR01 | Patent grant |